In particular, FASN, a key lipogenic enzyme that converts Acetyl-CoA and malonyl-CoA to palmitate, is drastically upregulated in many cancers such as breast, colon, lung, bladder, gastric, endometrial, ovary, kidney, pancreatic, head and neck, prostate, brain and melanoma (74–76). The gene discussed is FASN; the disease is cancer.